A phase I/II study of sepantronium bromide (YM155, survivin suppressor) with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer

Kelly, R.J. ; Thomas, A. ; Rajan, A. ; Chun, G. ; Lopez-Chavez, A. ; Szabo, E. ; Spencer, S. ; Carter, C.A. ; Guha, U. ; Khozin, S. ; Poondru, S. ; Van Sant, C. ; Keating, A. ; Steinberg, S.M. ; Figg, W. ; Giaccone, G.

Annals of oncology, 2013-10, Vol.24 (10), p.2601-2606 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível